Symed Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ESZOPICLONE, with a corresponding US DMF Number 28171.
Remarkably, this DMF maintains an Active status since its submission on April 01, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 22, 2014, and payment made on June 10, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II